Related content

A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction

By Govier F.   Potempa A.-J.   Kaufman J.   Denne J.   Kovalenko P.   Ahuja S.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2709-2723

Elsevier

Access to resources Recommend Favorite

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus

By Korytkowski M.   Bell D.   Jacobsen C.   Suwannasari R.   FlexPenR Study Team  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2836-2848

Elsevier

Access to resources Recommend Favorite

Effects of food on the bioavailability of gepirone from extended-release tablets in humans: results of two open-label crossover studies

By Fabre L.F.   Timmer C.J.  

Current Therapeutic Research, Vol. 64, Iss. 8, 2003-09 ,pp. : 580-598

Elsevier

Access to resources Recommend Favorite

Peginterferon- -2a (40kD) and Ribavirin in Patients with Chronic Hepatitis C: A Phase II Open-Label Study

By Sulkowski M.  

BioDrugs, Vol. 16, Iss. 2, 2002-02 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study

By Shimizu M.   Ogawa K.   Sasaki H.   Uehara Y.   Otsuka Y.   Okumura H.   Kusaka M.   Hasuda T.   Yamada T.   Mochizuki S.  

Current Therapeutic Research, Vol. 64, Iss. 9, 2003-11 ,pp. : 707-714

Elsevier

Access to resources Recommend Favorite